The Bulletin
The Times


.

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV at Center of International Innovation for Technology and Science

  • Written by The Bulletin

Another significant step towards the success of ICVAX®

HONG KONG SAR - Media OutReach Newswire - 27 May 2026 - Immuno Cure Group ("Immuno Cure"), headquartered at Hong Kong Science Park, is pleased to announce the inauguration of the research facility for its HIV therapeutic DNA vaccine ("ICVAX®") at the Center of International Innovation for Technology and Science ("CIITS") located in Hetao, Shenzhen.

Read more: Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV...

hacklink esim balkanzlibraryzlibraryz-libraryFanatikbetcasibomcasibomjojobetjustintvtaraftariumjojobethacklink panelmarsbahisvsf watchesjojobetuk casinos not on gamstopGamStopgüvenilir casino siteleri